NCT07334145Not yet recruiting
Effect of SGLT2 Inhibitors on Anemic CKD Patients
Effect of SGLT2 Inhibitors On Anemia in Patients With Chronic Kidney Disease (CKD)
Source: ClinicalTrials.gov · Last updated 14 Jan 2026
Brief summary (registry, in English)
anemia is a common complication of CKD patients and affect the quality of life and increase morbidity and mortality. managing anemia in CKD patients remains challenging conventional therapy including iron and ESAs which has its complications. the SGLT2 inhibitors have emerging evidence from major clinical trials in improving anemia in patients with CKD
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 31 Dec 2025
- Start date
- 1 Jan 2026
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Sohag University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07334145
What you commit to
- Study type: Observational
- Planned participants: 60
- From 1 Jan 2026 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- dialysis recent blood transfusion or ESA dose change within 8 weeks active malignancy or infection pregnancy or lactation history of recurrent DKA or sever volume depletion
Who the study is looking for
- age more than 18 years
- CKD stage 1\_4
- baseline hemoglobin 8.5 to 12.9 g/dl
- stable anemia regimen for more than 8 weeks
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag University Hospital Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.